Zynteglo

betibeglogene autotemcel

Approval

ApplicationBLA 125717
Approval dateAug 17, 2022
Approval year2022
Sponsorbluebird bio Inc

FDA-approved use

For treatment of adult and pediatric patients with ß-thalassemia who require regular red blood cell (RBC) transfusions

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Zynteglo: